Risk‐reducing medications for primary breast cancer: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risk‐reducing Medications for Primary Breast Cancer: a Network Meta‐analysis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Neo‐adjuvant_chemotherapy_for_invasive_bladder_cancer_Edited__no_change_to_conclusions_. Accessed 18 April 2024.
Risk‐reducing medications for primary breast cancer: a network meta‐analysis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Neo‐adjuvant_chemotherapy_for_invasive_bladder_cancer_Edited__no_change_to_conclusions_. Accessed April 18, 2024.
Risk‐reducing medications for primary breast cancer: a network meta‐analysis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Neo‐adjuvant_chemotherapy_for_invasive_bladder_cancer_Edited__no_change_to_conclusions_
Risk‐reducing Medications for Primary Breast Cancer: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Neo‐adjuvant_chemotherapy_for_invasive_bladder_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk‐reducing medications for primary breast cancer: a network meta‐analysis
ID - 432430
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Neo‐adjuvant_chemotherapy_for_invasive_bladder_cancer_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -